Title: "Creating new inhibitors to SARS-CoV-2 Macrodomain using Fragments, Neutrons, and Entropy!"
Abstract: SARS-CoV-2 counteracts the immune response through the action of the nsp3 macrodomain, an enzyme that removes ADP-ribosylation marks from host proteins. This enzyme is a promising antiviral target because catalytic mutations render viruses nonpathogenic. I will discuss the discovery of the first cell-active inhibitors for this protein and how several structural technologies, including high throughput fragment screening, neutron crystallography, active learning, and ensemble modeling of protein conformational dynamics led to their discovery.
See more of Dr. Fraser's research on his website: https://fraserlab.com/
Location and Address
Eberly 307